Santen Pharmaceutical Investor
Santen is a Japanese pharmaceutical company specializing in the development and manufacturing of ophthalmic products.
Total Funding:
59000000 EUR
Headquarters:
United States
Funding Status:
M&A
Employee Number:
1001-5000
Last Funding Type:
Series D
Number Of Exists:
3
Last Funding Date:
2009-09-26
Investors Number:
8
Founded Date:
1890-01-01
Industry:
Biotechnology, Health Care, Manufacturing, Science and Engineering